MedPath

DURVENA, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Photochemical Tissue Passivation Treatment of Saphenous Vein Grafts in CABG

Not Applicable
Active, not recruiting
Conditions
Coronary Artery Disease
Interventions
Device: DurVena Photochemical Tissue Passivation
First Posted Date
2023-11-29
Last Posted Date
2024-10-21
Lead Sponsor
DurVena, Inc.
Target Recruit Count
4
Registration Number
NCT06150872
Locations
🇺🇿

Republican Scientific Center of Emergency Medical Care, Tashkent, Uzbekistan

© Copyright 2025. All Rights Reserved by MedPath